Studies Investigate Relationship Between New Treatment and Reduction in Dysautonomia Symptoms in MS Patients
Synergy Health has published a new study, the first in a series, investigating the relationship between treatment for CCSVI (and its successor treatment, TVAM therapy) and the improvement of the symptoms of dysautonomia among M.S. Patients and other groups suffering from autonomic dysfunction. Read our latest study here: http://phl.sagepub.com/content/early/2020/11/18 While
Join Our Network: